01/09/2009
Teens with arthritis need transition help (UPI)
MINNEAPOLIS, Jan. 8 (UPI) -- One in five U.S. teens with arthritis gets counseling on how to transfer to adult-oriented physicians and to obtain adult health insurance, researchers say.
MORE INFO
|
01/08/2009
Adolescents With Arthritis Need More Information When Transitioning To Adult Care (Medical News Today)
Helping adolescents with arthritis develop the skills and secure resources to assure that their health care needs are met as they transition to adulthood is an important issue in the U.S. In general, the frequency of which young people with special health care needs receive transition services is low and, to date, no studies have examined this frequency.
MORE INFO
|
01/07/2009
Adolescents With Arthritis Need More Information When Transitioning To Adult Care (Science Daily)
Helping adolescents with arthritis develop the skills and secure resources to assure that their health care needs are met as they transition to adulthood is an important issue in the US.
MORE INFO
|
01/07/2009
Manitowoc woman joins Arthritis Foundations Wis. chapter (Manitowoc Herald Times Reporter)
WEST ALLIS Marisa Greguoli of Manitowoc recently joined the Arthritis Foundations Wisconsin chapter as the administrative assistant to the development department.
MORE INFO
|
01/07/2009
UCB obtains FDA complete response letter for arthritis drug (Pharmaceutical Business Review)
UCB, a biopharmaceutical company, has announced that the FDA has issued a complete response letter relating to the biologics license application of Cimzia, the first PEGylated anti-TNF, for the treatment of rheumatoid arthritis.
MORE INFO
|
01/09/2009
US FDA issues complete response letter to UCB on Cimzia (PharmaBiz)
UCB announced that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) relating to the Biologics License Application (BLA) of Cimzia (certolizumab pegol), the first PEGylated anti-TNF, for the treatment of rheumatoid arthritis (RA).
MORE INFO
|
01/07/2009
Axis sees potential in test for arthritis (The Herald)
Axis-Shield, the Scottish-Norwegian maker of medical diagnostic kits, yesterday said it had developed and manufactured a new test for the early diagnosis of rheumatoid arthritis and that it had the potential to alleviate the suffering of millions of people.
MORE INFO
|
01/08/2009
New therapy helps boy with rare disease (Reuters via Yahoo! News)
A drug used to suppress the immune system in cancer and rheumatoid arthritis has helped extend the life of a Minnesota boy struggling with a rare and deadly form of the genetic disorder Pompe disease.
MORE INFO
|
01/06/2009
UCB Receives Complete Response Letter From U.S. FDA For Use Of Cimzia® In Rheumatoid Arthritis Patients (Medical News Today)
UCB announced today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) relating to the Biologics License Application (BLA) of Cimzia® (certolizumab pegol), the first PEGylated anti-TNF, for the treatment of rheumatoid arthritis (RA).
MORE INFO
|
01/08/2009
Sucampo Completes Enrollment in Its Phase 2 Trial of Cobiprostone for the Prevention of NSAID-Induced Ulcers (Centre Daily Times)
Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) an international biopharmaceutical company, today announced that its wholly owned subsidiary, Sucampo Pharma Americas, Inc., has completed enrollment of its phase 2 clinical trial of cobiprostone designed to evaluate the compound’s efficacy and safety for the prevention of ulcers and other gastrointestinal injuries in arthritis patients treated with ...
MORE INFO
|